Powerful Herbal Extracts Found Effective for Pain Reduction and Increased Mobility

Rainbow Light Introduces Safe, Effective, Natural Remedies to Address Both Acute and Chronic Inflammation for Immediate Relief and Long-Term Wellness

Research Supports Boswellia and Hops Extracts for Pain Reduction and Increased Mobility

Two recent clinical trials have studied proprietary concentrated extracts of Boswellia: Aflapin® and 5-Loxin®. Both were associated with a significant improvement in joint function and pain reduction in patients with osteoarthritis (Sengupta et al, 2008; Sengupta et al, 2010). Significant improvements in pain score and functional ability were recorded as early as seven days after initiation of the study in the treatment group supplemented with Aflapin®. Note: Since these studies were conducted, the Aflapin® brand name has changed to Après flex®.

Human clinical studies show that Perluxan® (a proprietary, standardized Hops extract) intake had a fast-acting effect on mean pain relief after only two hours following the first dose. By the end of the second week, it was clear that Perluxan helped relieve minor pain during normal daily activities and may have improved mobility (Jager R et al, 2010). Santa Cruz, Calif. (August 19, 2011) – Injury, surgery or damage to the body triggers acute inflammation. Pain, redness and swelling are all signs of acute, or short-term, inflammation, which is the body’s way of protecting against further harm and facilitating healing. Systemic, chronic inflammation may result from lifestyle or dietary factors, or if the body is out of balance and fails to end the inflammatory cycle. Chronic Inflammation is suspected to be an underlying cause of many illnesses from Alzheimer’s to cancer, diabetes and more. Many people are looking for safe, natural alternatives to address pain and inflammation for both short-term and extended use. Consumer interest in herbal remedies remains strong, with sales expected to exceed $93 billion by 2015, according to the new report released this year from Global Industry Analysts, Inc. To meet consumer demand for effective, research-based solutions for acute and chronic inflammation, Rainbow Light® will introduce two new remedies this October: TheraMend™ Recovery and TheraMend™ COX-2 Flex.

TheraMend Recovery addresses acute inflammation resulting from injury or damage to the body, supporting the natural healing process and mobility with a highly concentrated herbal extract of white willow, studied and traditionally used for soreness, plus a patented curcumin extract (Meriva®) and boswellia extract that work to inhibit inflammation and cartilage damage. TheraMend Recovery uniquely provides proteolytic enzymes that digest excess fibrin, support cellular repair and promote a healthy inflammation response.

TheraMend COX-2 Flex provides long-term support for chronic inflammation by easing soreness, supporting connective tissue restoration and promoting a healthy inflammation response. TheraMend COX-2 Flex delivers standardized botanical extracts of hops (Perluxan®) and boswellia (Après flex®), plus absorption-enhanced curcumin (Meriva®), all studied for their targeted effects on reducing pro-inflammatory markers found in the joints, skin, gastro-intestinal tract and throughout the body. TheraMend COX-2 Flex provides an advanced, targeted formula that supports optimal range of motion and enhances daily well-being.

TheraMend Recovery and TheraMend COX-2 Flex are the newest offerings in the Herbal Prescriptives™ line, combining Rainbow Light’s expertise in the latest scientific research as well as time-honored herbal traditions and solid nutritional science. Every Herbal Prescriptives formula is backed by the Herbal IQ™ Guarantee, Rainbow Light’s rigorous quality assurance program:

• Qualified herbalists perform a thorough research review of the selected herbs and combinations.
• Each product delivers therapeutic, research-based potencies and combinations formulated by fourth-generation herbalist Christopher Hobbs, Ph.D., L.Ac.
• All ingredients go through rigorous identity verification and purity testing, and are formulated at Rainbow Light’s GMP-compliant, certified organic, USA-based facility.

“Since it is challenging for most consumers to purchase herbal ingredients and combine them into the correct potencies for home use, Rainbow Light has formulated Herbal Prescriptives to provide safe, effective solutions,” says Christopher Hobbs, Director of Herbal Science at Rainbow Light. “In my 30 years of clinical practice and through my Ph.D. research, I’ve studied the pharmacology and chemistry of herbal medicine to ensure efficacy and safety for the consumer.”

Dr. Hobbs’s new book, “Integrative Herbalism: The New Science of Herbal Medicine and Applications” will be available where natural products are sold in October, 2011. Dr. Hobbs will also participate in a panel discussion on Integrative Approaches to Inflammation, Pain and Chronic Disease at Natural Products Expo East in Baltimore, MD on Friday, September 23.

For more information on Rainbow Light’s Herbal Prescriptives product line visit: www.rainbowlight.com.

Media Contact:
Sharon Dressen
(330) 472-3768 or sharond@rlns.com
Manager Product Information, Education and Outreach